共 12 条
[1]
Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. Morrissey JJ,Klahr S. American Journal of Physiology .
[2]
Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatin. Kim SY,Guijarro C,O′Donnell MP,et al. Kidney International . 1995
[3]
Angiotensin Ⅱ participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. Ruiz-ortega M,Bustos C,Hernandez-presa MA,et al. J Immunol . 1998
[4]
Chemokines and renal disease. Wenzel UO. American Journal of Kidney Diseases . 1995
[5]
Gamma interferon stimulates monocyte chemotactic protein (MCP-1) in human mesangial cells. Grandaliano G,Valente AJ,Rozek MM,et al. Journal of Laboratory and Clinical Medicine . 1994
[6]
Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats. Kato S,Luyckx VA,Ots M,et al. Kidney International . 1999
[7]
Detection of urinary MCP-1 in patients with diabetic nephropathy. Saitoh A,Sekizuka K,Hayashi T,et al. Nephron . 1998
[8]
A high glucose concentration stimulates the expression of monocyte chemotactic peptide-1 in human mesangial cells. Ihm CG,Park JK,Hong SP,et al. Nephron . 1998
[9]
Oxidative modification of Low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation. Kamanna VS,Pai R,Roh DD,et al. Laboratory Investigation . 1996
[10]
Monocyte chemotactic peptide-1 in diabetic nephropathy. Ihm CG. Kidney International .